Solv, Q4 EPS

Solventum Corp. stock falls Friday, underperforms market
Shares of Solventum Corp. shed 4.42% to $79.75 Friday, on what proved to be an all-around positive trading session for the ...
Solventum forecasts annual profit above estimates on strong surgical product sales
M spin-off Solventum forecast annual profit above analyst estimates on Thursday, betting on strong sales of its wound care and surgical sterilization products.
Solventum price target raised to $75 from $73 at Wells Fargo
Wells Fargo raised the firm’s price target on Solventum (SOLV) to $75 from $73 and keeps an Equal Weight rating on the shares. The Q4 beat was ...
Solventum In The Early Stages Of A Multiyear Turnaround Effort
Solventum faces significant challenges in its turnaround, including slow-growing core businesses, share loss, and margin ...
Nelson Peltz’s Trian Pushes Solventum to Further Simplify Business
Activist investor Trian Fund Management plans to push Solventum to separate more of its businesses after the company’s $4.1 ...
Solventum price target raised to $84 from $75 at Piper Sandler
Piper Sandler raised the firm’s price target on Solventum (SOLV) to $84 from $75 and keeps a Neutral rating on the shares. The firm notes ...
Tariffs loom for Solventum, which has plants in China, Canada and Mexico.
As tariffs loom, 3M-spinoff Solventum’s operating margins are continuing to shrink while its investors look toward the ...